| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total revenues | $1.46B+11.1% | $1.32B+12.8% | $1.17B-100.0% | $2.46T |
| Cost of goods | $10.51B+31.2% | $8.01B+37.1% | $5.84B-99.9% | $4.64T |
| Cost of services | $885.4M+11.0% | $797.3M+12.1% | $711.3M-100.0% | $1.73T |
| Gross profit | $1.52B+19.8% | $1.27B+11.2% | $1.14B-99.9% | $1.35T |
| Selling, general, and administrative expenses | $1.22B+5.5% | $1.16B+7.2% | $1.08B-99.9% | $1.13T |
| Operating income | $295.3M+173.5% | $108.0M+85.7% | $58.1M-100.0% | $187.83B |
| Loss on extinguishment of debt | $12.7M | — | — | — |
| Interest expense, net | $157.3M-17.4% | $190.5M-29.9% | $271.9M-99.9% | $233.58B |
| Income (loss) from continuing operations before income taxes | $137.9M+244.7% | -$95.3M+55.4% | -$213.8M+99.5% | -$45.75B |
| Income tax expense (benefit) | $33.1M+225.6% | -$26.4M+16.3% | -$31.5M-100.4% | $8.46B |
| Net income (loss) from continuing operations | $104.8M+252.0% | -$68.9M+62.2% | -$182.3M | — |
| Income from discontinued operations, net of income taxes | $84.3M+74.2% | $48.4M+90.4% | $25.4M | — |
| Net income (loss) | $189.1M+1021.6% | -$20.5M+86.9% | -$156.8M+99.7% | -$54.22B |
| Net loss attributable to noncontrolling interests included in continuing operations | -$1.6M+36.8% | -$2.5M-10.2% | -$2.2M+99.3% | -$312.0M |
| Net income (loss) attributable to BrightSpring Health Services, Inc. and subsidiaries | $190.7M+1155.6% | -$18.1M+88.3% | -$154.6M+99.7% | -$53.91B |
| Continuing operations | $480+241.2% | -$340+77.8% | -$2K | — |
| Discontinued operations | $390+56.0% | $250+13.6% | $220 | — |
| Net income (loss) per share | $870.00+1066.7% | -$90.00+93.1% | -$1310.00-184.8% | -$460.00 |
| Basic | $202.6M+5.0% | $193.0M+63.7% | $117.9M+0.0% | $117.8M |
| Diluted | $219.8M+13.9% | $193.0M+63.7% | $117.9M+0.0% | $117.8M |
| Products | ||||
| Services | ||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.